Cor Vasa 2020, 62(6):595-601 | DOI: 10.33678/cor.2020.036

(The Role of PET/CT in Non-perfusion Cardiology)

David Zogala
Ústav nukleární medicíny, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice v Praze

The positron emission tomography combined with computer tomography (PET/CT) is a well established imag- ing modality in the oncological practice. The most frequently used radiopharmaceutical is 2-deoxy-2-(18F)fluoro-D-glucose (FDG). Due to the unspecific nature of its biodistribution high uptake of FDG reflects also increased metabolic turnover in the cells mediating inflammatory reaction. The most important role of FDG PET/CT in cardiac non-perfusion imaging is in the detection of the inflammation of the heart compartments, ev. implantable devices. The neoplastic diseases of the heart represent another (less frequent) possible role for PET imaging. A review of literature and clinical experiences are presented in this review article.

Keywords: Cardiovascular inflammation, PET, PET/CT, Positron emission tomography,

Received: April 7, 2020; Revised: April 7, 2020; Accepted: May 4, 2020; Published: December 11, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zogala D. (The Role of PET/CT in Non-perfusion Cardiology). Cor Vasa. 2020;62(6):595-601. doi: 10.33678/cor.2020.036.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Prendergast BD. The changing face of infective endocarditis. Heart 2006;7:879-885. Go to original source... Go to PubMed...
    2. Spacek M, Belohlavek O, Votrubova J, et al. Diagnostics of "non-acute" vascular prosthesis infection using 18F-FDG PET/CT: our experience with 96 prostheses. Eur J Nucl Med Mol Imaging 2009;5:850-858. Go to original source... Go to PubMed...
    3. Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015;44:3075-3128. Go to original source... Go to PubMed...
    4. Slart RH. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging 2018;7:1250-1269. Go to original source... Go to PubMed...
    5. Sethi I, Baum YS, Grady EE. Current Status of Molecular Imaging of Infection: A Primer. AJR Am J Roentgenol 2019;2:300-308. Go to original source... Go to PubMed...
    6. Beneš J, Gregor P, Mokráček A. Infekční endokarditida. Doporučené postupy diagnostiky, léčby, dispenzarizace a profylaxe. Cor Vasa 2007;49:106-120.
    7. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 1994;3:200-209. Go to original source... Go to PubMed...
    8. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;4:633-638. Go to original source... Go to PubMed...
    9. Saby L, Laas O, Habib G, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol 2013;23:2374-2382. Go to original source... Go to PubMed...
    10. Rouzet F, Chequer R, Benali K, et al. Respective performance of 18F-FDG PET and radiolabeled leukocyte scintigraphy for the diagnosis of prosthetic valve endocarditis. J Nucl Med 2014;12:1980-1985. Go to original source... Go to PubMed...
    11. Erba PA, Conti U, Lazzeri E, et al. Added value of 99mTc- -HMPAO-labeled leukocyte SPECT/CT in the characterization and management of patients with infectious endocarditis. J Nucl Med 2012;8:1235-1243. Go to original source... Go to PubMed...
    12. Williams G, Kolodny GM. Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low- -carbohydrate diet. AJR Am J Roentgenol 2008;2:151-156. Go to original source... Go to PubMed...
    13. Osborne MT, Hulten EA, Murthy VL, et al. Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation. J Nucl Cardiol 2017;1:86-99. Go to original source... Go to PubMed...
    14. Erba PA, Lancellotti P, Vilacosta I, et al. Recommendations on nuclear and multimodality imaging in IE and CIED infections. Eur J Nucl Med Mol Imaging 2018;10:1795-1815. Go to original source... Go to PubMed...
    15. Dorbala S, Di Carli MF, Delbeke D, et al. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med 2013;8:1485-1507. Go to original source... Go to PubMed...
    16. Gomes A, Glaudemans AWJM, Touw DJ, et al. Diagnostic value of imaging in infective endocarditis: a systematic review. Lancet Infect Dis 2017;17:e1-e14. Go to original source... Go to PubMed...
    17. Pizzi MN, Roque A, Fernandez-Hidalgo N, et al. Improving the Diagnosis of Infective Endocarditis in Prosthetic Valves and Intracardiac Devices With 18F-Fluordeoxyglucose Positron Emission Tomography/Computed Tomography Angiography: Initial Results at an Infective Endocarditis Referral Center. Circulation 2015;12:1113-1126. Go to original source... Go to PubMed...
    18. Pizzi MN, Roque A, Cuellar-Calabria H, et al. (18)F-FDG-PET/CTA of Prosthetic Cardiac Valves and Valve-Tube Grafts: Infective Versus Inflammatory Patterns. JACC Cardiovasc Imaging 2016;10:1224-1227. Go to original source... Go to PubMed...
    19. Cantoni V, Sollini M, Green R, et al. Comprehensive meta- -analysis on [18F] FDG PET/CT and radiolabelled leukocyte SPECT-SPECT/CT imaging in infectious endocarditis and cardiovascular implantable electronic device infections. Clinical and Translational Imaging 2018;1:3-18. Go to original source...
    20. Van Riet J, Hill EE, Gheysens O, et al. (18)F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis. Eur J Nucl Med Mol Imaging 2010;6:1189-1197. Go to original source... Go to PubMed...
    21. Abikhzer G, Martineau P, Gregoire J, et al. [(18)F]FDG-PET CT for the evaluation of native valve endocarditis. J Nucl Cardiol 2020 Mar 16. doi: 10.1007/s12350-020-02092-6. Epub ahead of print. PMID: 32180137. Go to original source... Go to PubMed...
    22. Maurer AH, Burshteyn M, Adler LP, et al. How to differentiate benign versus malignant cardiac and paracardiac 18F FDG uptake at oncologic PET/CT. Radiographics 2011;5:1287-1305. Go to original source... Go to PubMed...
    23. Scholtens AM, Swart LE, Verberne HJ, et al. Confounders in FDG-PET/CT Imaging of Suspected Prosthetic Valve Endocarditis. JACC Cardiovasc Imaging 2016;12:1462-1465. Go to original source... Go to PubMed...
    24. Mahmood M, Kendi AT, Ajmal S, et al. Meta-analysis of 18F-FDG PET/CT in the diagnosis of infective endocarditis. J Nucl Cardiol 2019;3:922-935. Go to original source... Go to PubMed...
    25. Juneau D, Golfam M, Hazra S, et al. Molecular Imaging for the diagnosis of infective endocarditis: A systematic literature review and meta-analysis. Int J Cardiol 2018:183-188. Go to original source... Go to PubMed...
    26. Tam MC, Patel VN, Weinberg RL, et al. Diagnostic Accuracy of FDG PET/CT in Suspected LVAD Infections: A Case Series, Systematic Review, and Meta-Analysis. JACC Cardiovasc Imaging 2020;13:1191-1202. Go to original source... Go to PubMed...
    27. Dell'Aquila AM, Mastrobuoni S, Alles S, et al. Contributory Role of Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis and Clinical Management of Infections in Patients Supported With a Continuous-Flow Left Ventricular Assist Device. Ann Thorac Surg 2016;1:87-94. Go to original source... Go to PubMed...
    28. Kim MS, Kim EK, Choi JY, et al. Clinical Utility of [(18)F]FDG-PET /CT in Pericardial Disease. Curr Cardiol Rep 2019;9:107-113. Go to original source... Go to PubMed...
    29. Lawal I, Sathekge M. F-18 FDG PET/CT imaging of cardiac and vascular inflammation and infection. Br Med Bull 2016;1:55-74. Go to original source... Go to PubMed...
    30. Grani C, Eichhorn C, Biere L, et al. Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected Myocarditis. J Am Coll Cardiol 2017;16:1964-1976. Go to original source... Go to PubMed...
    31. Nensa F, Bamberg F, Rischpler C, et al. Hybrid cardiac imaging using PET/MRI: a joint position statement by the European Society of Cardiovascular Radiology (ESCR) and the European Association of Nuclear Medicine (EANM). Eur Radiol 2018;10:4086-4101. Go to original source... Go to PubMed...
    32. Rischpler C, Woodard PK. PET/MR Imaging in Cardiovascular Imaging. PET Clin 2019;2:233-244. Go to original source... Go to PubMed...
    33. Chareonthaitawee P, Beanlands RS, Chen W, et al. Joint SNMMI-ASNC Expert Consensus Document on the Role of (18)F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring. J Nucl Med 2017;8:1341-1353. Go to original source... Go to PubMed...
    34. Piekarski E, Benali K, Rouzet F. Nuclear Imaging in Sarcoidosis. Semin Nucl Med 2018;3:246-260. Go to original source... Go to PubMed...
    35. Kim SJ, Pak K, Kim K. Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis. J Nucl Cardiol 2019 Jan 2. doi: 10.1007/s12350-018-01582-y. Epub ahead of print. PMID: 30603894. Go to original source... Go to PubMed...
    36. Saponara M, Ambrosini V, Nannini M, et al. (18)F-FDG- -PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature. Ther Adv Med Oncol 2018;10:1758835918793569. Go to original source... Go to PubMed...
    37. Rahbar K, Seifarth H, Schafers M, et al. Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT. J Nucl Med 2012;6:856-863. Go to original source... Go to PubMed...
    38. Qin C, Shao F, Hu F, et al. (18)F-FDG PET/CT in diagnostic and prognostic evaluation of patients with cardiac masses: a retrospective study. Eur J Nucl Med Mol Imaging 2020;5:1083-1093. Go to original source... Go to PubMed...
    39. Nensa F, Tezgah E, Poeppel TD, et al. Integrated 18F-FDG PET/MR imaging in the assessment of cardiac masses: a pilot study. J Nucl Med 2015;2:255-260. Go to original source... Go to PubMed...
    40. Rob D, Kuchynka P, Palecek T, et al. A rare case of regressively changed lipomatous hypertrophy of the interatrial septum presenting with anemia and recurrent fever. Cardiovasc Pathol 2016;2:161-164. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes